Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $17.77 down -0.28% from its previous closing price of $17.82. In other words, the price has decreased by -$0.28 from its previous closing price. On the day, 0.85 million shares were traded. ZLAB stock price reached its highest trading level at $18.66 during the session, while it also had its lowest trading level at $17.72.
Ratios:
For a deeper understanding of Zai Lab Limited ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $55.
BofA Securities Downgraded its Buy to Neutral on March 03, 2025, whereas the target price for the stock was revised from $29 to $36.10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 21 ’25 when Edmondson Frazor Titus III sold 14,328 shares for $19.78 per share. The transaction valued at 283,408 led to the insider holds 27,737 shares of the business.
Edmondson Frazor Titus III bought 14,328 shares of ZLAB for $283,408 on Nov 21 ’25. On Nov 03 ’25, another insider, Chen Yajing, who serves as the Chief Financial Officer of the company, sold 240 shares for $26.83 each. As a result, the insider received 6,439 and left with 17,444 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 1965251200 and an Enterprise Value of 19154718720. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.47 while its Price-to-Book (P/B) ratio in mrq is 2.59. Its current Enterprise Value per Revenue stands at 43.373 whereas that against EBITDA is -89.595.
Stock Price History:
The Beta on a monthly basis for ZLAB is 0.83, which has changed by -0.3193277 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $17.76. The 50-Day Moving Average of the stock is -27.06%, while the 200-Day Moving Average is calculated to be -43.74%.
Shares Statistics:
For the past three months, ZLAB has traded an average of 779.10K shares per day and 712780 over the past ten days. A total of 110.59M shares are outstanding, with a floating share count of 108.86M. Insiders hold about 2.12% of the company’s shares, while institutions hold 28.56% stake in the company. Shares short for ZLAB as of 1764288000 were 5037867 with a Short Ratio of 6.47, compared to 1761868800 on 5022907. Therefore, it implies a Short% of Shares Outstanding of 5037867 and a Short% of Float of 5.1599998000000005.
